Among the most popular fund investment industries, there are Biotechnology, Medical. Besides, a startup needs to be aged 1 and less years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Immunic
The usual cause for the fund is to invest in rounds with 6 partakers. Despite the IBG Risikokapitalfonds II GmbH & Co. KG, startups are often financed by LifeCare Partners, bmp Ventures, Life Sciences Partners. The meaningful sponsors for the fund in investment in the same round are Omega Funds, Life Sciences Partners, LifeCare Partners. In the next rounds fund is usually obtained by German Federal Ministry of Education and Research (BMBF).
The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017.
Related Funds
| Fund Name | Location |
| Alfresa Holdings | Japan, Tokyo |
| Andra AP-fonden | Göteborg, Sweden, Vastra Gotaland |
| Elizabeth Street Ventures | New York, New York, United States |
| Intertainment Media | Canada, Ontario, Toronto |
| Investir&+ | France, Ile-de-France, Paris |
| Madrone Capital Partners | California, Menlo Park, United States |
| Seattle Foundation | Seattle, United States, Washington |
| Tarsadia Investments | California, Newport Beach, United States |
| Tsukuba Bank | Ibaraki Prefecture, Japan, Tsukuba |
| Whitestone Investment Fund | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Immunic | $11M | 05 Sep 2017 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Immunic | $11M | 05 Sep 2017 | San Diego, California, United States |
